Search results
The page "Biosimilar pharmaceutical" does not exist. You can create a draft and submit it for review or request that a redirect be created, but consider checking the search results below to see whether the topic is already covered.
- A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product that is almost an identical copy of an original...95 KB (6,480 words) - 22:51, 13 May 2024
- 2010. "Amneal Pharmaceuticals, Inc. (AMRX)". SeekingAlpha. March 2, 2020. "Newly Merged Amneal Pharmaceuticals to Push into the Biosimilar Space". BioSpace...15 KB (1,189 words) - 20:36, 18 February 2024
- third wave of bio-pharmaceuticals that are going off patent in 2026–27. Intas Pharmaceuticals is a large company in the global biosimilar monoclonal antibodies...49 KB (5,048 words) - 08:53, 24 July 2024
- Adalimumab (redirect from Adalimumab biosimilar)2017, the FDA approved German pharmaceutical company Boehringer Ingelheim's biosimilar, Cyltezo. In 2017, the biosimilars Amgevita, Solymbic, Imraldi,...91 KB (6,895 words) - 01:51, 16 July 2024
Pharma launches biosimilar in Europe". The Hindu. ISSN 0971-751X. Retrieved 3 October 2021. "Intas Pharmaceuticals launches biosimilar in Europe". The...14 KB (1,116 words) - 10:43, 8 July 2024
Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...28 KB (2,582 words) - 06:37, 13 July 2024
Biocon (category Pharmaceutical companies established in 1978)novel biologics as well as biosimilar insulins and antibodies, which are sold in India as branded formulations. Biocon's biosimilar products are also sold...30 KB (2,613 words) - 18:01, 2 July 2024- S.; Kenett, Dan A. (2008). "Quality by Design applications in biosimilar pharmaceutical products". Accreditation and Quality Assurance. 13 (12): 681–690...15 KB (1,703 words) - 11:02, 1 August 2023
Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...22 KB (2,424 words) - 21:23, 25 July 2024
Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...24 KB (2,227 words) - 08:42, 1 July 2024- Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...18 KB (2,103 words) - 02:00, 15 July 2024
Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...7 KB (488 words) - 09:27, 26 June 2024
Pharmaceuticals introduced a biosimilar variant of the anti-diabetic drug Liraglutide, marking a pioneering endeavor within the Indian pharmaceutical...13 KB (1,080 words) - 11:12, 28 June 2024- Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...8 KB (754 words) - 00:25, 28 February 2024
2004, which marked Teva's entry into biosimilars' market. In 2005, Teva opened a new, state-of-the-art pharmaceutical manufacturing plant in Har Hotzvim...69 KB (5,707 words) - 16:40, 12 July 2024
Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...189 KB (15,336 words) - 15:31, 28 July 2024- Lupin Limited (redirect from Lupin Pharmaceutical)certain biosimilars including regulatory fillings and obtaining marketing authorization in Japan. In 2019, Lupin exited the generic pharmaceuticals business...23 KB (2,108 words) - 01:45, 29 May 2024
- Sandoz (category Pharmaceutical companies of Switzerland)Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis...35 KB (2,761 words) - 03:18, 24 June 2024
- Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...16 KB (1,248 words) - 11:22, 24 July 2024
Industrial Development Organization Public health Generic drugs biosimilar Pharmaceutical patents criticism Test data exclusivity Doha Declaration World...114 KB (11,998 words) - 14:21, 27 July 2024
- delay—for years and even decades—competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs. In the telecommunications
- Reforms to the regulatory and legal processes that prevent generics and biosimilars from entering the market. Reforms to the patent system to prevent abuse